Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

Lieping Chen, Patrick McGowan, Stephanie Ashe, Janet Johnston, Yiwen Li, Ingegerd Hellström, Karl Erik Hellström

Research output: Contribution to journalArticlepeer-review


A costimulatory signal through B7 to its counter-receptor CD28 on T cells enhances T cell activation. We have generated recombinant retroviruses containing cDNA for murine B7 and transduced a panel of murine tumor lines with varying immunogenicity to study the effect of B7 costimulation on antitumor immunity. In contrast to the progressive outgrowth of all wild-type (B7-) tumors in unimmunized syngeneic mice, four immunogenic tumors, lymphoma RMA, EL4, mastocytoma P815, and melanoma E6B2, regressed completely when transduced with the B7 gene. In contrast, four nonimmunogenic tumors, sarcomas MCA101, MCA102, and Ag104, and melanoma B16, remained tumorigenic after transduction of the B7 gene. Immunization with B7-tranduced immunogenic tumors enhanced protective immunity and increased specific cytotoxic T lymphocyte (CTL) activity against the respective wild-type tumors as compared to immunization with nontransduced or mock-transduced tumors. Moreover, cocultivation of CTL with B7-transduced EL4 cells augmented the specificity of tumor-reactive CTL in long-term cultures. Treatment by injection of B7-transduced tumor cells cured 60% of mice with established wild-type EL4 lymphoma. In contrast, immunization with nonimmunogenic tumors transduced with B7 did not provide protective immunity and did not increase specific CTL activity. Our results show that tumor immunogenicity is critical to the outcome of costimulation of T cell-mediated tumor immunity by B7.

Original languageEnglish (US)
Pages (from-to)523-532
Number of pages10
JournalJournal of Experimental Medicine
Issue number2
StatePublished - Feb 1 1994
Externally publishedYes

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity'. Together they form a unique fingerprint.

Cite this